Oxcarbazepine is Used for managing partial-onset seizures. It was first introduced by Novartis Pharmaceuticals Corp in its drug Trileptal on Jan 14, 2000. Another drug containing Oxcarbazepine is Oxtellar Xr. 24 different companies have introduced drugs containing Oxcarbazepine.
Oxcarbazepine Patents
Given below is the list of patents protecting Oxcarbazepine, along
with the drug name that holds that patent and the company name owning that
drug.
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Oxcarbazepine's patents.
Latest Legal Activities on Oxcarbazepine's Patents
Given below is the list recent legal activities going on the following patents of Oxcarbazepine.
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List
Oxcarbazepine Generic API Manufacturers
Several generic applications have been filed for Oxcarbazepine. The first generic version for Oxcarbazepine was by Sun Pharmaceutical Industries Ltd and was approved on Oct 9, 2007. And the latest generic version is by Rubicon Research Private Ltd and was approved on Mar 5, 2024.
Given below is the list of companies who have filed for
Oxcarbazepine generic, along with the locations of their manufacturing plants worldwide.
1. AJANTA PHARMA LTD
Ajanta Pharma Ltd has filed for 3 different strengths of generic version for Oxcarbazepine. Given below are the
details of the strengths of this generic introduced by
Ajanta Pharma Ltd.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
300MG
tablet, extended release
Discontinued
ORAL
N/A
Feb 22, 2024
600MG
tablet, extended release
Discontinued
ORAL
N/A
Feb 22, 2024
150MG
tablet, extended release
Discontinued
ORAL
N/A
Feb 22, 2024
Manufacturing Plant Locations
New
Ajanta Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Ajanta Pharma Ltd as present at those locations.
Country
City
Firm Name
India
Aurangabad
Ajanta Pharma Ltd.
2. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 1 generic for Oxcarbazepine. Given below are the
details of the strengths of this generic introduced by
Alkem Labs Ltd.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
300MG/5ML
suspension
Prescription
ORAL
AB
Mar 18, 2023
3. AMNEAL PHARMS
Amneal Pharmaceuticals has filed for 1 generic for Oxcarbazepine. Given below are the
details of the strengths of this generic introduced by
Amneal Pharms.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
300MG/5ML
suspension
Prescription
ORAL
AB
Sep 17, 2012
4. ANI PHARMS
Ani Pharmaceuticals Inc has filed for 3 different strengths of generic version for Oxcarbazepine. Given below are the
details of the strengths of this generic introduced by
Ani Pharms.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
150MG
tablet
Prescription
ORAL
AB
Dec 11, 2007
300MG
tablet
Prescription
ORAL
AB
Dec 11, 2007
600MG
tablet
Prescription
ORAL
AB
Dec 11, 2007
5. ANNORA PHARMA
Annora Pharma Private Ltd has filed for 3 different strengths of generic version for Oxcarbazepine. Given below are the
details of the strengths of this generic introduced by
Annora Pharma.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
300MG
tablet
Prescription
ORAL
AB
Jan 11, 2022
150MG
tablet
Prescription
ORAL
AB
Jan 11, 2022
600MG
tablet
Prescription
ORAL
AB
Jan 11, 2022
Manufacturing Plant Locations
New
Annora Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Annora Pharma as present at those locations.
Country
City
Firm Name
India
Hyderabad
Annora Pharma Private Limited
6. APOTEX
Apotex Inc has filed for 3 different strengths of generic version for Oxcarbazepine. Given below are the
details of the strengths of this generic introduced by
Apotex.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
150MG
tablet, extended release
Prescription
ORAL
AB
Jul 13, 2023
300MG
tablet, extended release
Prescription
ORAL
AB
Jul 13, 2023
600MG
tablet, extended release
Prescription
ORAL
AB
Jul 13, 2023
Manufacturing Plant Locations
New
Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.
Country
City
Firm Name
United States
Weston
Apotex Corp.
Canada
Brantford
Apotex Pharmachem Inc.
Winnipeg
Apotex Fermentation Inc.
Etobicoke
Apotex, Inc.
North York
Apotex Inc.
Richmond Hill
Apotex Inc.
Toronto
Apotex Inc.
India
Bangalore
Apotex Research Private Limited - Bioequivalence Centre
Bengaluru
Apotex Research Private Limited
Bangalore
Apotex Pharmachem India Pvt Ltd.
7. AUCTA
Aucta Pharmaceuticals Inc has filed for 1 generic for Oxcarbazepine. Given below are the
details of the strengths of this generic introduced by
Aucta.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
300MG/5ML
suspension
Prescription
ORAL
AB
Nov 30, 2022
8. BIOCON PHARMA
Biocon Pharma Inc has filed for 1 generic for Oxcarbazepine. Given below are the
details of the strengths of this generic introduced by
Biocon Pharma.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
300MG/5ML
suspension
Prescription
ORAL
AB
Mar 1, 2024
Manufacturing Plant Locations
New
Biocon Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Biocon Pharma as present at those locations.
Country
City
Firm Name
India
Bengaluru
Biocon Pharma Limited
9. BIONPHARMA
Bionpharma Inc has filed for 1 generic for Oxcarbazepine. Given below are the
details of the strengths of this generic introduced by
Bionpharma.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
300MG/5ML
suspension
Prescription
ORAL
AB
Nov 4, 2022
Manufacturing Plant Locations
New
Bionpharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bionpharma as present at those locations.
Country
City
Firm Name
United States
Princeton
Bionpharma Inc.
10. BRECKENRIDGE PHARM
Breckenridge Pharmaceutical Inc has filed for 3 different strengths of generic version for Oxcarbazepine. Given below are the
details of the strengths of this generic introduced by
Breckenridge Pharm.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
150MG
tablet
Prescription
ORAL
AB
Jan 11, 2008
300MG
tablet
Prescription
ORAL
AB
Jan 11, 2008
600MG
tablet
Prescription
ORAL
AB
Jan 11, 2008
Manufacturing Plant Locations
New
Breckenridge Pharm's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Breckenridge Pharm as present at those locations.
Country
City
Firm Name
United States
Boca Raton
Breckenridge Pharmaceutical, Inc.
Berlin
Breckenridge Pharmaceutical, Inc
11. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 1 generic for Oxcarbazepine. Given below are the
details of the strengths of this generic introduced by
Chartwell Rx.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
300MG/5ML
suspension
Prescription
ORAL
AB
Jun 21, 2021
12. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Oxcarbazepine. Given below are the
details of the strengths of this generic introduced by
Glenmark Pharms Ltd.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
150MG
tablet
Prescription
ORAL
AB
Oct 9, 2007
600MG
tablet
Prescription
ORAL
AB
Oct 9, 2007
300MG
tablet
Prescription
ORAL
AB
Oct 9, 2007
13. HETERO LABS LTD III
Hetero Labs Ltd Unit Iii has filed for 1 generic for Oxcarbazepine. Given below are the
details of the strengths of this generic introduced by
Hetero Labs Ltd Iii.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
300MG/5ML
suspension
Prescription
ORAL
AB
Oct 20, 2023
14. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Oxcarbazepine. Given below are the
details of the strengths of this generic introduced by
Hikma.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
150MG
tablet
Discontinued
ORAL
N/A
Oct 9, 2007
300MG
tablet
Discontinued
ORAL
N/A
Oct 9, 2007
600MG
tablet
Discontinued
ORAL
N/A
Oct 9, 2007
300MG/5ML
suspension
Discontinued
ORAL
N/A
Oct 3, 2012
Manufacturing Plant Locations
New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
Country
City
Firm Name
United States
Eatontown
Hikma Pharmaceuticals USA, Inc.
Cherry Hill
Hikma Pharmaceuticals USA Inc.
Dayton
Hikma Injectables USA Inc
Carlsbad
Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Portugal
Terrugem Snt
Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman
Hikma Pharmaceuticals LLC
15. JUBILANT CADISTA
Jubilant Cadista Pharmaceuticals Inc has filed for 3 different strengths of generic version for Oxcarbazepine. Given below are the
details of the strengths of this generic introduced by
Jubilant Cadista.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
150MG
tablet
Discontinued
ORAL
N/A
Jan 25, 2010
300MG
tablet
Discontinued
ORAL
N/A
Jan 25, 2010
600MG
tablet
Discontinued
ORAL
N/A
Jan 25, 2010
Manufacturing Plant Locations
New
Jubilant Cadista's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Jubilant Cadista as present at those locations.
Country
City
Firm Name
United States
Salisbury
Jubilant Cadista Pharmaceuticals, Inc.
16. KANCHAN HLTHCARE
Kanchan Healthcare Inc has filed for 1 generic for Oxcarbazepine. Given below are the
details of the strengths of this generic introduced by
Kanchan Hlthcare.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
300MG/5ML
suspension
Prescription
ORAL
AB
Feb 14, 2024
17. RENEW PHARMS
Renew Pharmaceuticals Ltd has filed for 1 generic for Oxcarbazepine. Given below are the
details of the strengths of this generic introduced by
Renew Pharms.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
300MG/5ML
suspension
Discontinued
ORAL
N/A
Jul 9, 2021
18. RUBICON
Rubicon Research Private Ltd has filed for 4 different strengths of generic version for Oxcarbazepine. Given below are the
details of the strengths of this generic introduced by
Rubicon.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
150MG
tablet
Prescription
ORAL
AB
Mar 5, 2024
600MG
tablet
Prescription
ORAL
AB
Mar 5, 2024
300MG
tablet
Prescription
ORAL
AB
Mar 5, 2024
300MG/5ML
suspension
Prescription
ORAL
AB
Aug 30, 2022
Manufacturing Plant Locations
New
Rubicon's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Rubicon as present at those locations.
Country
City
Firm Name
United States
Geismar
Rubicon, LLC
Indianapolis
Rubicon Foods LLC
Canada
Concord
Rubicon Research Canada Limited
India
Ambarnath
Rubicon Research Private Limited
19. SUN PHARM INDS
Sun Pharmaceutical Industries Ltd has filed for 3 different strengths of generic version for Oxcarbazepine. Given below are the
details of the strengths of this generic introduced by
Sun Pharm Inds.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
150MG
tablet
Prescription
ORAL
AB
Oct 9, 2007
300MG
tablet
Prescription
ORAL
AB
Oct 9, 2007
600MG
tablet
Prescription
ORAL
AB
Oct 9, 2007
20. SUN PHARM INDS LTD
Sun Pharmaceutical Industries Ltd has filed for 1 generic for Oxcarbazepine. Given below are the
details of the strengths of this generic introduced by
Sun Pharm Inds Ltd.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
300MG/5ML
suspension
Prescription
ORAL
AB
Jun 26, 2009
21. TARO
Taro Pharmaceutical Industries Ltd has filed for 3 different strengths of generic version for Oxcarbazepine. Given below are the
details of the strengths of this generic introduced by
Taro.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
600MG
tablet
Prescription
ORAL
AB
Nov 15, 2007
150MG
tablet
Prescription
ORAL
AB
Nov 15, 2007
300MG
tablet
Prescription
ORAL
AB
Nov 15, 2007
Manufacturing Plant Locations
New
Taro's manufacturing plants are situated in 3 countries - United States, Israel, Canada. Given below are the details of these plant locations as well as the firm names of Taro as present at those locations.
Country
City
Firm Name
United States
Hawthorne
Taro Pharmaceuticals U.S.A., Inc.
Honolulu
Taro Delight, LLC
Israel
Haifa
Taro Pharmaceutical Industries, Ltd.
Canada
Brampton
Taro Pharmaceuticals Inc.
22. ZYDUS
Zydus Worldwide Dmcc has filed for 3 different strengths of generic version for Oxcarbazepine. Given below are the
details of the strengths of this generic introduced by
Zydus.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
300MG
tablet
Discontinued
ORAL
N/A
Jul 3, 2023
600MG
tablet
Discontinued
ORAL
N/A
Jul 3, 2023
150MG
tablet
Discontinued
ORAL
N/A
Jul 3, 2023
Manufacturing Plant Locations
New
Zydus's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Zydus as present at those locations.
